Atea Pharmaceuticals, Inc.
TREATMENT OF HCV INFECTED PATIENTS WITH CIRRHOSIS
Last updated:
Abstract:
A pharmaceutical composition that includes a compound of the structure: ##STR00001## to treat an HCV infected patient with cirrhosis, and uses thereof.
Status:
Application
Type:
Utility
Filling date:
7 Oct 2020
Issue date:
21 Jan 2021